Xenon Pharmaceuticals to present azetukalner data at neurology meeting

April 7, 2026 8:42 AM

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) announced it will present five abstracts at the American Academy of Neurology Annual Meeting taking ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found